Targeting CD4+ T cells through gut microbiota: therapeutic potential of traditional Chinese medicine in inflammatory bowel disease
Xin Lu,
No information about this author
Yichuan Xv,
No information about this author
Weiye Hu
No information about this author
et al.
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2025,
Volume and Issue:
15
Published: March 3, 2025
Inflammatory
Bowel
Disease
(IBD)
is
an
autoimmune
disease
characterized
by
chronic
relapsing
inflammation
of
the
intestinal
tract.
Gut
microbiota
(GM)
and
CD4
+
T
cells
are
important
in
development
IBD.
A
lot
studies
have
shown
that
GM
their
metabolites
like
short-chain
fatty
acids,
bile
acids
tryptophan
can
be
involved
differentiation
through
various
mechanisms,
which
turn
regulate
immune
homeostasis
IBD
patients.
Therefore,
regulating
may
a
potential
therapeutic
direction
for
treatment
Many
Traditional
Chinese
Medicine
(TCM)
formulas
some
herbal
extracts
affect
cell
its
metabolites.
In
this
review,
we
mainly
focus
on
role
correlation
with
We
also
summarize
current
research
progress
regulation
process
TCM.
Language: Английский
Combination of Youhua Kuijie Prescription and sulfasalazine can alleviate experimental colitis via IL-6/JAK2/STAT3 pathway
Lili Tang,
No information about this author
Yuedong Liu,
No information about this author
Hongwu Tao
No information about this author
et al.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: Sept. 10, 2024
Youhua
Kuijie
prescription
(YHKJ)
is
a
hospital
preparation
that
composed
of
nine
kinds
herbs.
Sulfasalazine
(SASP)
widely
used
as
first-line
clinical
treatment
for
UC.
Traditional
Chinese
medicine
and
Western
have
their
own
advantages
in
the
UC,
mechanism
YHKJ
combined
with
SASP
UC
needs
to
be
investigated.
Language: Английский
Network Pharmacology to Reveal the Mechanism of Fufang Banmao Capsule for Treating Unresectable Primary Liver Cancer and Clinical Data Validation
Current Pharmaceutical Design,
Journal Year:
2024,
Volume and Issue:
30(35), P. 2785 - 2796
Published: Aug. 2, 2024
Fufang
Banmao
capsule
(FFBM),
a
traditional
Chinese
medicine,
has
been
used
to
treat
primary
liver
cancer
(PLC)
for
several
years.
However,
the
bioactive
ingredients,
and
mechanism
of
FFBM
treating
PLC
remains
unclear.
Our
objective
is
utilize
network
pharmacology
investigate
these
aspects
subsequently
validate
their
effectiveness
through
clinical
data.
Language: Английский